These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1666451)

  • 1. Venous thromboprophylaxis in the 1990s: a perspective.
    Fareed J
    Semin Thromb Hemost; 1991 Oct; 17(4):317-21. PubMed ID: 1666451
    [No Abstract]   [Full Text] [Related]  

  • 2. Thromboprophylaxis with heparin and low molecular weight heparin in elective hip surgery: current status and perspectives.
    Breyer HG
    Semin Thromb Hemost; 1991 Oct; 17(4):336-42. PubMed ID: 1666453
    [No Abstract]   [Full Text] [Related]  

  • 3. Low molecular weight heparins: prophylaxis of venous thromboembolism in surgical patients.
    Kakkar VV
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):9-19. PubMed ID: 9399405
    [No Abstract]   [Full Text] [Related]  

  • 4. Low molecular weight heparin for the prevention and treatment of venous thromboembolism.
    Raskob GE
    Curr Opin Pulm Med; 1996 Jul; 2(4):305-10. PubMed ID: 9363157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience of a low molecular weight heparin (Fragmin) in the prevention of thromboembolism after total hip replacement.
    Eriksson BI; Kälebo P; Risberg B
    Semin Thromb Hemost; 1993; 19 Suppl 1():122-7. PubMed ID: 8395714
    [No Abstract]   [Full Text] [Related]  

  • 6. Low molecular weight heparins and external pneumatic compression as options for venous thromboembolism prophylaxis: a surgeon's perspective.
    Caprini JA; Arcelus JI; Traverso CI; Hasty JH
    Semin Thromb Hemost; 1991 Oct; 17(4):356-66. PubMed ID: 1666456
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?
    Agnelli G
    Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776
    [No Abstract]   [Full Text] [Related]  

  • 8. [Low molecular weight heparin--preventive supplementation against postoperative venous thromboembolism].
    Bergqvist D
    Lakartidningen; 1990 Feb; 87(8):562-4. PubMed ID: 2155361
    [No Abstract]   [Full Text] [Related]  

  • 9. Advances in the prevention of venous thromboembolic disease in orthopaedics: the introduction of LMWH.
    Colwell CW; Paiement G; Pellegrini VD; Salvati EA; Stulberg BN
    Contemp Orthop; 1993 Dec; 27(6):551-77. PubMed ID: 10146586
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylaxis of venous thromboembolism in surgery.
    Verhaeghe R; Verstraete M
    Acta Chir Belg; 1997 Jun; 97(3):106-9. PubMed ID: 9224512
    [No Abstract]   [Full Text] [Related]  

  • 11. [Perioperative prevention of thromboembolism with low molecular weight heparin and postoperative bleeding complications].
    Hoffman R; Largiadèr F; Brütsch HP
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():1179-84. PubMed ID: 1983509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Low molecular weight heparin].
    Gillis S; Eldor A
    Harefuah; 1992 Mar; 122(5):309-12. PubMed ID: 1315300
    [No Abstract]   [Full Text] [Related]  

  • 13. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery.
    Bergqvist D
    Br J Surg; 2004 Aug; 91(8):965-74. PubMed ID: 15286956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When can the patient with deep venous thrombosis begin to ambulate?
    Aldrich D; Hunt DP
    Phys Ther; 2004 Mar; 84(3):268-73. PubMed ID: 14984299
    [No Abstract]   [Full Text] [Related]  

  • 15. [Non controlled prospective study of the efficacy and tolerance of a low molecular weight heparin].
    Wattrisse G; Lecoutre D; Groux-Pante C
    J Mal Vasc; 1991; 16(4):367-71. PubMed ID: 1665169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of thromboembolic disease in general surgery with clexane (enoxaparin).
    Combe S; Samama MM
    Semin Thromb Hemost; 1991; 17 Suppl 3():291-5. PubMed ID: 1661438
    [No Abstract]   [Full Text] [Related]  

  • 17. The relationship between ex vivo anti-factor Xa levels and efficacy/safety of low molecular weight heparin.
    Turpie AG
    Br J Clin Pract Suppl; 1989 Jan; 65():18-23; discussion 23-5. PubMed ID: 2554949
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of enoxaparine in preventing deep venous thrombosis following total hip prosthesis. Randomized multicenter prospective trial].
    Planes A; Vochelle N; Mazas F; Mansat C; Zucman J; Landais A; Pascariello JC; Weil D; Butel J
    Rev Chir Orthop Reparatrice Appar Mot; 1988; 74 Suppl 2():215-8. PubMed ID: 2852830
    [No Abstract]   [Full Text] [Related]  

  • 20. [Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin].
    Marx A; Huhle G; Hoffmann U; Wang LC; Schüle B; Jani L; Harenberg J
    Z Orthop Ihre Grenzgeb; 1999; 137(6):536-9. PubMed ID: 10666863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.